Letter
Proton beam therapy for cancer
Randomised controlled trials of proton beam therapy are needed
Cite this as:
BMJ
2012;344:e3193
- Ian H Kunkler, consultant in clinical oncology1
- 1Edinburgh Cancer Centre, Edinburgh EH4 2XU, UK
- i.kunkler{at}ed.ac.uk
Epstein questions whether the investment of £250m (€307m; $405m) in two NHS UK proton facilities is premature.1 The ability of protons to confine the high dose volume to the tumour while minimising the dose to adjacent normal tissues is theoretically attractive in, for example, selected paediatric intracranial tumours, skull …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
Social bookmarking